Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C129H223N3O54 |
| Molecular Weight | 2680.1386 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 64 / 64 |
| E/Z Centers | 7 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](CCCCC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O[C@H](C[C@H](O)[C@H](O)C(\C)=C\[C@H](O)C[C@@H](C)[C@H](O)C(=O)N\C=C\C(=O)NCCCO)[C@H](O)[C@@H](O)[C@@H]1O)C[C@H]2O[C@]%10(CCCCCCC[C@H](O)C[C@H]3O[C@@](O)(C[C@H](O)[C@@H](C)\C=C\[C@@H](O)CC[C@@H](O)[C@@H](O)[C@@H]4C[C@@H](O)[C@H](O)[C@@H](C[C@@H](O)[C@H](O)C[C@H]5O[C@@H](C[C@H](O)\C=C/C=C/C[C@@H](O)[C@H](O)[C@H](O)C\C=C/C(=C)CC[C@H](O)[C@@H](O)[C@H](O)[C@H](C)C[C@H]6O[C@H](\C=C/[C@@H](O)[C@H](O)C[C@@H]7C[C@@H]8C[C@H](O7)[C@@H](CC[C@H]9O[C@H](CN)C[C@H]9O)O8)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@@H](O)[C@@H]5O)O4)[C@H](O)[C@H](O)[C@H]3O)C[C@@H](C)C[C@@]2(C)O%10
InChI
InChIKey=CWODDUGJZSCNGB-HQNRRURTSA-N
InChI=1S/C129H223N3O54/c1-62(29-33-81(143)108(158)103(153)68(7)47-93-111(161)117(167)110(160)91(180-93)36-35-76(138)82(144)51-73-50-74-53-92(178-73)90(177-74)38-37-89-85(147)52-75(61-130)179-89)23-20-28-78(140)105(155)77(139)26-18-13-16-25-70(135)48-94-112(162)118(168)113(163)97(181-94)55-84(146)83(145)54-95-107(157)87(149)57-96(182-95)106(156)80(142)34-32-69(134)31-30-65(4)88(150)60-129(176)125(174)123(173)115(165)99(184-129)49-71(136)24-15-10-9-11-19-40-128-59-64(3)58-127(8,186-128)100(185-128)44-63(2)22-14-12-17-27-79(141)109(159)116(166)120(170)122(172)124-121(171)119(169)114(164)98(183-124)56-86(148)102(152)66(5)45-72(137)46-67(6)104(154)126(175)132-42-39-101(151)131-41-21-43-133/h13,16,18,20,23,25,30-31,35-36,39,42,45,63-65,67-100,102-125,133-150,152-174,176H,1,9-12,14-15,17,19,21-22,24,26-29,32-34,37-38,40-41,43-44,46-61,130H2,2-8H3,(H,131,151)(H,132,175)/b18-13+,23-20-,25-16-,31-30+,36-35-,42-39+,66-45+/t63-,64-,65-,67+,68+,69+,70+,71-,72-,73-,74+,75-,76+,77+,78+,79+,80+,81-,82+,83+,84+,85+,86-,87+,88-,89+,90+,91+,92-,93+,94-,95+,96-,97+,98+,99+,100+,102+,103+,104-,105-,106+,107-,108+,109-,110+,111-,112-,113+,114-,115-,116-,117-,118+,119+,120+,121-,122-,123+,124-,125+,127+,128-,129-/m0/s1
Palytoxin is the most potent marine toxin known that was isolated from a zoanthid of the genus Palythoa and Cyanobacteria (Trichodesmium). Palytoxin is a potent vasoconstrictor that damages the ionic gradient of the cells, causing cell death. This toxin has a strong potential for toxicity in humans and animals that is why it causes great concern worldwide. It is crucial to remove this toxin and start an aggressive topical therapy as soon as possible.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Oxidative stress induced by palytoxin in human keratinocytes is mediated by a H+-dependent mitochondrial pathway. | 2013-01-01 |
|
| Palytoxin induces cell lysis by priming a two-step process in mcf-7 cells. | 2011-08-15 |
|
| Effects of the marine toxin palytoxin on human skin keratinocytes: role of ionic imbalance. | 2011-03-28 |
|
| Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression. | 2010-04 |
|
| Palytoxin toxicity after acute oral administration in mice. | 2009-12-15 |
|
| Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin. | 2009-12-01 |
|
| Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: in vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins. | 2006-01 |
|
| Light and electron microscopic observation of experimental palytoxin poisoning in mice. | 1992 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
77734-91-9
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
77734-92-0
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
ALTERNATIVE | |||
|
m8370
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID90423027
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
11105289
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
Palytoxin
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
OQ17NC0MOV
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
11077-03-5
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
PRIMARY | |||
|
11077-03-5
Created by
admin on Mon Mar 31 18:45:39 GMT 2025 , Edited by admin on Mon Mar 31 18:45:39 GMT 2025
|
ALTERNATIVE |
SUBSTANCE RECORD
